Cargando…

STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS

BACKGROUND: A maximal safe resection has been shown as an independent prognosis factor for high grade glioma (HGG). Intraoperative photo dynamics diagnosis (PDD) facilitates an increased rate of tumor resection, thereby taking an important role in accomplishment of “ maximal safe resection “ along w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Keiichi, Saito, Kuniaki, Shimada, Daisuke, Matsumoto, Yoshie, Shimizu, Saki, Iijima, Shouhei, Noguchi, Akio, Shibahara, Jyunji, Shiokawa, Yoshiaki, Nagane, Motoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213277/
http://dx.doi.org/10.1093/noajnl/vdz039.081
_version_ 1783531769501319168
author Kobayashi, Keiichi
Saito, Kuniaki
Shimada, Daisuke
Matsumoto, Yoshie
Shimizu, Saki
Iijima, Shouhei
Noguchi, Akio
Shibahara, Jyunji
Shiokawa, Yoshiaki
Nagane, Motoo
author_facet Kobayashi, Keiichi
Saito, Kuniaki
Shimada, Daisuke
Matsumoto, Yoshie
Shimizu, Saki
Iijima, Shouhei
Noguchi, Akio
Shibahara, Jyunji
Shiokawa, Yoshiaki
Nagane, Motoo
author_sort Kobayashi, Keiichi
collection PubMed
description BACKGROUND: A maximal safe resection has been shown as an independent prognosis factor for high grade glioma (HGG). Intraoperative photo dynamics diagnosis (PDD) facilitates an increased rate of tumor resection, thereby taking an important role in accomplishment of “ maximal safe resection “ along with neuro-navigation and monitoring of motor nerve function. Since the approval of aminolevulinic acid (5-ALA) for PDD in 2013 in Japan, we have been utilizing the PDD when HGG is suspected by preoperative assessments. Here we retrospectively analyze clinical findings in PDD-mediated tumor resection. METHODS: From February 2014 to March 2019, 285 consecutive patients (132 females) with suspected HGG underwent total of 302 PDD-mediated resection. Median age was 61 yo (13–90). A single oral dose of 5-ALA 20 mg/kg was given within three hours before microsurgery. Positivity of excited fluorescence was assessed qualitatively under surgical microscope. RESULTS: Among 195 gliomas, the fluorescence positivity rates were 89.6% (120/134) for glioblastoma, 40.5% (15/37) for grade III, and 13.6% (3/22) for grade II. The positive rates for other histologies were 30.2% (13/43) for malignant lymphoma, 32.1% (9/28) for metastatic brain tumor, 0% (0/7) for meningioma (include atypical), and 4.5% (1/22) for other types. In gliomas the high positivity correlated with histological grades, while all fluorescence-positive grade II gliomas were recurrent tumors. Serious adverse events were not observed. CONCLUSIONS: The qualitative PDD showed a clinical utility to aid accurate resection in glioblastoma, whereas its positivity was inconsistent in lower grade gliomas as well as other malignant brain tumors. This unreliability might attribute, at least in part, to fluorescent intensity heterogeneity in situ, a reduced excitation by an inappropriate radiation angle of the light source, and the qualitative fluorescence detection. Impacts of introducing quantitative detection system as well as molecular and histopathological features on better discrimination will be discussed.
format Online
Article
Text
id pubmed-7213277
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72132772020-07-07 STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS Kobayashi, Keiichi Saito, Kuniaki Shimada, Daisuke Matsumoto, Yoshie Shimizu, Saki Iijima, Shouhei Noguchi, Akio Shibahara, Jyunji Shiokawa, Yoshiaki Nagane, Motoo Neurooncol Adv Abstracts BACKGROUND: A maximal safe resection has been shown as an independent prognosis factor for high grade glioma (HGG). Intraoperative photo dynamics diagnosis (PDD) facilitates an increased rate of tumor resection, thereby taking an important role in accomplishment of “ maximal safe resection “ along with neuro-navigation and monitoring of motor nerve function. Since the approval of aminolevulinic acid (5-ALA) for PDD in 2013 in Japan, we have been utilizing the PDD when HGG is suspected by preoperative assessments. Here we retrospectively analyze clinical findings in PDD-mediated tumor resection. METHODS: From February 2014 to March 2019, 285 consecutive patients (132 females) with suspected HGG underwent total of 302 PDD-mediated resection. Median age was 61 yo (13–90). A single oral dose of 5-ALA 20 mg/kg was given within three hours before microsurgery. Positivity of excited fluorescence was assessed qualitatively under surgical microscope. RESULTS: Among 195 gliomas, the fluorescence positivity rates were 89.6% (120/134) for glioblastoma, 40.5% (15/37) for grade III, and 13.6% (3/22) for grade II. The positive rates for other histologies were 30.2% (13/43) for malignant lymphoma, 32.1% (9/28) for metastatic brain tumor, 0% (0/7) for meningioma (include atypical), and 4.5% (1/22) for other types. In gliomas the high positivity correlated with histological grades, while all fluorescence-positive grade II gliomas were recurrent tumors. Serious adverse events were not observed. CONCLUSIONS: The qualitative PDD showed a clinical utility to aid accurate resection in glioblastoma, whereas its positivity was inconsistent in lower grade gliomas as well as other malignant brain tumors. This unreliability might attribute, at least in part, to fluorescent intensity heterogeneity in situ, a reduced excitation by an inappropriate radiation angle of the light source, and the qualitative fluorescence detection. Impacts of introducing quantitative detection system as well as molecular and histopathological features on better discrimination will be discussed. Oxford University Press 2019-12-16 /pmc/articles/PMC7213277/ http://dx.doi.org/10.1093/noajnl/vdz039.081 Text en © The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kobayashi, Keiichi
Saito, Kuniaki
Shimada, Daisuke
Matsumoto, Yoshie
Shimizu, Saki
Iijima, Shouhei
Noguchi, Akio
Shibahara, Jyunji
Shiokawa, Yoshiaki
Nagane, Motoo
STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
title STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
title_full STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
title_fullStr STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
title_full_unstemmed STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
title_short STMO-01 APPLICATION OF THE AMINOLEVULINIC ACID HYDROCHLORIDE FOR INTRAOPERATIVE DETECTION OF MALIGNANT BRAIN TUMORS
title_sort stmo-01 application of the aminolevulinic acid hydrochloride for intraoperative detection of malignant brain tumors
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213277/
http://dx.doi.org/10.1093/noajnl/vdz039.081
work_keys_str_mv AT kobayashikeiichi stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT saitokuniaki stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT shimadadaisuke stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT matsumotoyoshie stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT shimizusaki stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT iijimashouhei stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT noguchiakio stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT shibaharajyunji stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT shiokawayoshiaki stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors
AT naganemotoo stmo01applicationoftheaminolevulinicacidhydrochlorideforintraoperativedetectionofmalignantbraintumors